Joinn Laboratories (China) Co Ltd
Company Profile
Business description
Joinn Laboratories (China) Co Ltd is a non-clinical contract research organization(CRO) focused on drug safety assessment. It operates in three segments: Non-clinical studies services include drug safety assessment, drug metabolism & pharmacokinetics (DMPK) studies, & pharmacology & efficacy studies; Clinical trial & related services segment provides early-stage services such as clinical CRO services, co-managed phase I clinical research units, & bioanalytical services, and: Sales of research models engages in the design, production, breeding, & sales of research models, currently including non-human primates and rodents. The majority is from the Non-Clinical studies services. Its geographical segments are China, the United States, and Other countries, of which the majority is from China.
Contact
A5 Rongjing East Street
Beijing Economic-Technological Development Area
Beijing100176
CHNT: +86 1067869966
Sector
Healthcare
Stock type
Defensive
Industry
Diagnostics & Research
Fiscal Year End
31 December 2025
Employees
2,652
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,591.10 | 19.70 | 0.23% |
CAC 40 | 7,864.44 | 46.05 | -0.58% |
DAX 40 | 23,999.17 | 123.23 | -0.51% |
Dow JONES (US) | 41,859.09 | 1.35 | -0.00% |
FTSE 100 | 8,739.26 | 47.20 | -0.54% |
HKSE | 23,679.99 | 135.68 | 0.58% |
NASDAQ | 18,925.73 | 53.09 | 0.28% |
Nikkei 225 | 37,200.92 | 215.05 | 0.58% |
NZX 50 Index | 12,619.01 | 43.24 | -0.34% |
S&P 500 | 5,842.01 | 2.60 | -0.04% |
S&P/ASX 200 | 8,366.10 | 17.40 | 0.21% |
SSE Composite Index | 3,382.96 | 2.77 | 0.08% |